The 30-year cardiovascular risk profile of South Africans with diagnosed diabetes, undiagnosed diabetes, pre-diabetes or normoglycaemia: The Bellville, South Africa pilot study

Cardiovascular Journal of Africa

Volumn 23, Issue 1, 2012, Pages 5-11

  Matsha, Tandi E ^a   Hassan, Mogamat S ^a   Kidd, Martin ^b   Erasmus, Rajiv T ^c  

^a CAPE PENINSULA UNIVERSITY OF TECHNOLOGY   (South Africa)

^b STELLENBOSCH UNIVERSITY   (South Africa)

^c UNIVERSITY OF STELLENBOSCH   (South Africa)

Author keywords

Cardiovascular diseases; Diabetes mellitus; Epidemiology; Obesity; South Africa

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHOLESTEROL BLOOD LEVEL; CROSS-SECTIONAL STUDY; DIABETES MELLITUS; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; IMPAIRED GLUCOSE TOLERANCE; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; MALE; PILOT STUDY; RETROSPECTIVE STUDY; SOUTH AFRICA; TRIACYLGLYCEROL BLOOD LEVEL; CARDIOVASCULAR DISEASES; HYPERGLYCEMIA; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS; HUMANS; HYPERGLYCEMIA; PILOT PROJECTS; RISK FACTORS; SOUTH AFRICA;

EID: 84857350450     PISSN: 19951892     EISSN: None     Source Type: Journal    
DOI: 10.5830/CVJA-2010-087     Document Type: Article

References (43)

1. Levitt NS, Katzenellenbogen JM, Bradshaw D, Hoffman MN, Bonnici F. The prevalence and identification of risk factors for NIDDM in urban Africans in Cape Town, South Africa. Diabetes Care 1993; 16: 601-607. (Pubitemid 23097209)
2. Erasmus RT, Blanco Blanco E, Okesina AB, Matsha T, Gqweta Z, Mesa JA. Prevalence of diabetes mellitus and impaired glucose tolerance in factory workers from Transkei, South Africa. S Afr Med J 2001; 91: 157-160. (Pubitemid 32208570)
3. Motala AA, Pirie FJ, Gouws E, Amod A, Omar MA. High incidence of type 2 diabetes mellitus in South African Indians: a 10-year follow-up study. Diabet Med 2003; 20: 23-30. (Pubitemid 36098862)
4. Gu K, Cowie CC, Harris MI. Mortality in adults with and without diabetes in a national cohort of the US population, 1971-1993. Diabetes Care 1998; 21: 1138-1145. (Pubitemid 28368522)
5. Bradshaw D, Groenewald P, Laubscher R, Nannan N, Nojilana B, Norman R, et al. Initial burden of disease estimates for South Africa, 2000. S Afr Med J 2003; 93: 682-688. (Pubitemid 37368850)
6. Bradshaw D, Norman R, Pieterse D, Levitt NS; South African Comparative Risk Assessment Collaborating Group. Estimating the burden of disease attributable to diabetes in South Africa in 2000. S Afr Med J 2007; 97: 700-706.
7. DECODE study group. Is the current definition for diabetes relevant to mortality risk from all causes and cardiovascular and noncardiovascular diseases? Diabetes Care 2003; 26: 688-696.
8. Bartnik M, Rydén L, Ferrari R, Malmberg K, Pyörälä K, Simoons M, et al; Euro Heart Survey investigators. The prevalence of abnormal glucose regulation in patients with coronary artery disease across Europe. The Euro Heart Survey on diabetes and the heart. Eur Heart J 2004; 25: 1880-1890. (Pubitemid 39452604)
9. Temelkova-Kurktschiev TS, Koehler C, Henkel E, Leonhardt W, Fuecker K, Hanefeld M. Postchallenge plasma glucose and glycemic spikes are more strongly associated with atherosclerosis than fasting glucose or HbA1c level. Diabetes Care 2000; 23: 1830-1834.
10. Petersen JL, McGuire DK. Impaired glucose tolerance and impaired fasting glucose - a review of diagnosis, clinical implications and management. Diab Vasc Dis Res. 2005; 2: 9-15. (Pubitemid 40333199)
11. Anderson KM, Odell PM, Wilson PW, Kannel WB. Cardiovascular disease risk profiles. Am Heart J 1991; 121: 293-298.
12. Conroy RM, Pyörälä K, Fitzgerald AP, Sans S, Menotti A, De Backer G, et al; SCORE project group. Estimation of ten-year risk of fatal cardiovascular disease in Europe: the SCORE project. Eur Heart J 2003; 24: 987-1003. (Pubitemid 36712275)
13. D'Agostino RB Sr, Vasan RS, Pencina MJ, Wolf PA, Cobain M, Massaro JM, Kannel WB. General cardiovascular risk profile for use in primary care: the Framingham Heart Study. Circulation 2008; 117: 743-753. (Pubitemid 351640675)
14. Coleman R, Stevens R, Holman R. The Oxford Risk Engine: a cardiovascular risk calculator for individuals with or without type 2 diabetes. Diabetes 2007; 56 (Suppl 1): A170.
15. Simmons RK, Coleman RL, Price HC, Holman RR, Khaw KT, Wareham NJ, Griffin SJ. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care 2009; 32: 708-713.
16. Pencina MJ, D'Agostino RB Sr, Larson MG, Massaro JM, Vasan RS. Predicting the 30-year risk of cardiovascular disease: the framingham heart study. Circulation 2009; 119: 3078-3084.
17. Hobbs FD, Jukema JW, Da Silva PM, McCormack T, Catapano AL. Barriers to cardiovascular disease risk scoring and primary prevention in Europe. Q J Med 2010 Aug 4. [Epub ahead of print].
18. D'Agostino RB Sr, Grundy S, Sullivan LM, Wilson P; CHD risk prediction group. Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation. J Am Med Assoc 2001; 286: 180-187. (Pubitemid 32640849)
19. Steyn K, Sliwa K, Hawken S, Commerford P, Onen C, Damasceno A, et al; INTERHEART investigators in Africa. Risk factors associated with myocardial infarction in Africa: the INTERHEART Africa study. Circulation 2005; 112: 3554-3561. (Pubitemid 43739532)
20. Mayosi BM, Flisher AJ, Lalloo UG, Sitas F, Tollman SM, Bradshaw D. The burden of non-communicable diseases in South Africa. Lancet 2009; 374: 934-947.
21. City of Cape Town Census 2001 http://www.capetown.gov.za (21 June 2007).
22. Ewing JA. Detecting alcoholism: The CAGE questionnaire. J Am Med Assoc 1984; 252: 1905-1907.
23. Bradshaw D, Bourne D, Schneider M, Sayed R. Mortality patterns of chronic diseases of lifestyle in South Africa. In: Fourie J, Steyn K, eds. Chronic Diseases of Lifestyle in South Africa. Medical Research Council (MRC) Technical Report. Tygerberg: MRC, 1995; 5-31.
24. World Health Organization (WHO). International Society of Hypertension Guidelines for the Management of Hypertension. J Hypertens 1999; 17: 151-183.
25. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998; 15: 539-553. (Pubitemid 28319935)
26. Narayan KM, Boyle JP, Thompson TJ, Gregg EW, Williamson DF. Effect of BMI on lifetime risk for diabetes in the US. Diabetes Care 2007; 30:1562-1566. (Pubitemid 46871171)
27. Fox CS, Pencina MJ, Wilson PW, Paynter NP, Vasan RS, D'Agostino RB Sr. Lifetime risk of cardiovascular disease among individuals with and without diabetes stratified by obesity status in the Framingham heart study. Diabetes Care 2008; 31: 1582-1584.
28. Ntyintyane LM, Panz VR, Raal FJ, Gill GV. Metabolic syndrome, undiagnosed diabetes mellitus and insulin resistance are highly prevalent in urbanised South African blacks with coronary artery disease. Cardiovasc J S Afr 2006; 17: 50-55. (Pubitemid 43966315)
29. Steyn K, Levitt NS, Hoffman M, Marais AD, Fourie JM, Lambert EV, et al. The global cardiovascular diseases risk pattern in a peri-urban working-class community in South Africa. The Mamre study. Ethn Dis 2004; 14: 233-242. (Pubitemid 39302865)
30. Lloyd-Jones DM, Wilson PW, Larson MG, Beiser A, Leip EP, D'Agostino RB, Levy D. Framingham risk score and prediction of lifetime risk for coronary heart disease. Am J Cardiol 2004; 94: 20-24. (Pubitemid 38813447)
31. Opie LH. Heart disease in Africa. Lancet 2006; 368: 449-450. (Pubitemid 44142766)
32. McLarty DG, Pollit C, Swai ABM. Diabetes in South Africa. Diabet Med 1990; 7: 670-684.
33. Tollman SM, Kahn K, Sartorius B, Collinson MA, Clark SJ, Garenne ML. Implications of mortality transition for primary health care in rural South Africa: a population-based surveillance study. Lancet 2008; 372: 893-901.
34. Alberts M, Urdal P, Steyn K, Stensvold I, Tverdal A, Nel JH, Steyn NP. Prevalence of cardiovascular diseases and associated risk factors in a rural black population of South Africa. Eur J Cardiovasc Prev Rehabil 2005; 12: 347-354. (Pubitemid 41192166)
35. Peltzer K. Health behaviour among black and white South Africans. J R Soc Promot Hlth 2002; 122:187-193. (Pubitemid 35173989)
36. Van Rooyen JM, Kruger HS, Huisman HW, Wissing MP, Margetts BM, Venter CS, Vorster HH. An epidemiological study of hypertension and its determinants in a population in transition: the THUSA study. J Hum Hypertens 2000; 14: 779-787. (Pubitemid 32015829)
37. Tibazarwa K, Ntyintyane L, Sliwa K, Gerntholtz T, Carrington M, Wilkinson D, Stewart S.A time bomb of cardiovascular risk factors in South Africa: results from the Heart of Soweto Study 'Heart Awareness Days'. Int J Cardiol 2009; 132: 233-239.
38. Nathan DM, Cleary PA, Backlund JY, Genuth SM, Lachin JM, Orchard TJ, et al Diabetes Control and Complications Trial/Epidemiology of Diabetes Interventions and Complications (DCCT/EDIC) Study Research Group. Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes. N Engl J Med 2005; 353: 2643-2653. (Pubitemid 41817713)
39. Stratton IM, Adler AI, Neil HA, Matthews DR, Manley SE, Cull CA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. Br Med J 2000; 321: 405-412. (Pubitemid 30609442)
40. Stettler C, Allemann S, Jüni P, Cull CA, Holman RR, Egger M, et al. Glycemic control and macrovascular disease in types 1 and 2 diabetes mellitus: Meta-analysis of randomized trials. Am Heart J 2006; 152: 27-38. (Pubitemid 43974725)
41. Gaede P, Lund-Andersen H, Parving HH, Pedersen O. Effect of a multifactorial intervention on mortality in type 2 diabetes. N Engl J Med 2008; 358: 580-591. (Pubitemid 351214285)
42. Mazzone T, Chait A, Plutzky J. Cardiovascular disease risk in type 2 diabetes mellitus: insights from mechanistic studies. Lancet 2008; 371: 1800-1809. (Pubitemid 351697956)
43. Matsha T, Hassan S, Bhata A, Yako Y, Fanampe B, Somers A, et al. Metabolic syndrome in 10-16-year-old learners from the Western Cape, South Africa: Comparison of the NCEP ATP III and IDF criteria. Atherosclerosis 2009; 205: 363-366.